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Liquid extraction surface analysis ﬁeld asymmetric
waveform ion mobility spectrometry mass
spectrometry for the analysis of dried blood spots†
Rian L. Griﬃths, Alex Dexter, Andrew J. Creese and Helen J. Cooper*
Liquid extraction surface analysis (LESA) is a surface sampling technique that allows electrospray mass
spectrometry analysis of a wide range of analytes directly from biological substrates. Here, we present
LESA mass spectrometry coupled with high ﬁeld asymmetric waveform ion mobility spectrometry (FAIMS)
for the analysis of dried blood spots on ﬁlter paper. Incorporation of FAIMS in the workﬂow enables gas-
phase separation of lipid and protein molecular classes, enabling analysis of both haemoglobin and a
range of lipids (phosphatidylcholine or phosphatidylethanolamine, and sphingomyelin species) from a
single extraction sample. The work has implications for multiplexed clinical assays of multiple analytes.
Introduction
Liquid extraction surface analysis (LESA) mass spectrometry is
a direct surface sampling technique originally developed by
Van Berkel and co-workers.1,2 Analytes are extracted from the
surface via a liquid micro-junction between a pipette tip and
the sample surface. This approach enables direct sampling of
a variety of biological analytes, such as drugs,3 lipids4,5 and
proteins,6–8 from a range of solid surfaces prior to electrospray
ionisation (ESI). Substrates analysed by LESA include thin
tissue sections,3,6,9 bacterial colonies grown on agar,7 dried
blood spots on card8,10,11 and polymeric surfaces.4,12 Other
direct analysis approaches that have been applied to the analy-
sis of dried blood spots include desorption electrospray ionis-
ation (DESI),13 direct analysis in real time (DART)14,15 and
paperspray.16–18
Previous analyses of dried blood spots (DBS) on card have
shown that peaks corresponding to the intact α-globin and
β-globin sub-units can be detected via LESA MS.8,11 More
recently, we have shown that intact tetrameric haemoglobin
can be detected by LESA MS of dried blood spots.12 LESA MS
therefore has potential applications in the analysis of haemo-
globinopathies, the most commonly inherited disorders.
Edwards et al. showed that LESA MS of dried blood spots was
suitable for the screening of variants HbS, HbC, HbD, HbE,
and β-thalassemia.8,19
Haemoglobin is highly abundant in blood samples
(between 120 and 130 mg mL−1 (ref. 20)), however a range of
other analytes, such as lipid species, are also present and have
been implicated as biomarkers for disease profiling. Analysis
of DBS samples, rather than whole blood, can be preferential
in a clinical setting owing to the reduced sample volumes
required,21 the relative ease of storage compared to whole
blood or plasma22 and due to the reduced risk of infection
from certain blood borne diseases.23
Generally lipids are prepared from DBS samples by taking a
“punch” and extracting in methanolic solution before perform-
ing mass spectrometry analysis.24–27 Sandlers et al. used an LC
MS/MS approach to monitor 26:0 lyso-phosphotidylcholine as
a biomarker of X-linked adrenoleukodystrophy24 in samples
eluted from DBS. Koulman et al. showed that the lipid profile
in samples from DBS was a reliable indicator of lipid meta-
bolism in infants.25 These researchers also reported that moni-
toring of lipid species from DBS samples yielded more precise
results in comparison to plasma samples, owing to the preven-
tion of degradation processes upon drying.25 Faller et al. have
shown that the monitoring of phosphatidylethanolamine
species extracted from DBS samples by LC MS/MS can be
determined as reliably as from whole blood,26 which could be
a viable method of monitoring alcohol misuse. Recently,
Dénes et al. reported the detection of a wide range of meta-
bolites, including lipids, from similarly prepared samples.27
They also showed that their methods were suﬃciently robust
for disease profiling.
A method which combines the benefits of direct sampling
of dried blood spots (elimination of sample preparation) with
the ability to separate molecule classes, e.g., lipids and
proteins, would be of great benefit: such a method would
†Electronic supplementary information (ESI) available. See DOI: 10.1039/
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overcome the challenge of interference from haemoglobin
enabling direct analysis of lipids. Furthermore, separation of
the diﬀerent sub-units of haemoglobin could be advantageous
in the diagnosis of haemoglobinopathies.
Here, we combine field asymmetric waveform ion mobility
spectrometry (FAIMS) with LESA of DBS. We have recently
demonstrated the benefits of coupling of FAIMS to LESA MS
analysis of thin tissue sections and bacterial colonies growing
on agar.28 FAIMS separates ions at atmospheric pressure on the
basis of their diﬀerential ion mobilities in high and low electric
fields29,30 and oﬀers advantages including improved signal-to-
noise ratios, reduced chemical noise31 and separation of iso-
meric analytes.32,33 In the current work, we show that LESA
FAIMS mass spectrometry of DBS enables separation of the hae-
moglobin α- and β-sub units from lipid species. Lipids identified
included phosphatidylcholine or phosphatidylethanolamine
species and sphingomyelin species. The lipids could not be
detected by LESA mass spectrometry in the absence of FAIMS.
Methods
Dried blood spots
The work was approved by the University of Birmingham
STEM Ethical Review Committee (ERN_14-0454). Dried blood
spots were acquired from healthy human adult donors via
finger prick onto NHS blood spot (Guthrie) cards, Ahlstrom
grade 226 filter paper ID Biological Systems, (Greenville, USA)
and dried overnight prior to analysis. Reproducibility data
were obtained from four technical replicates from each of two
biological replicates. DBS were sampled 1 day after collection
and 6 days after collection. Samples were stored in a covered
dish at room temperature.
Surface sampling
LESA sampling. LESA was carried out by use of a Triversa
Nanomate nanoelectrospray platform (Advion Biosciences,
Ithaca, USA). The dried blood spot samples were mounted
onto the LESA universal adaptor plate and an image was
acquired using an Epson Perfection V300 photo scanner. The
LESA Points software (Advion) was used to select the precise
location of the substrate to be sampled. The universal adapter
plate was placed in the Triversa Nanomate. A solution compris-
ing 1 : 1 methanol : (HPLC grade) water (both JT Baker, Deven-
ter, The Netherlands) with the addition of 1% formic acid
(Sigma-Aldrich Company Ltd, Dorset, U.K.) was used as the
extraction and ionisation solvent. In the extraction process,
10 µl of solvent was aspirated from the solvent well. The robotic
arm relocated to a position above the sample and descended to
a height of 1.6 mm above the surface. Four microlitres of
solvent was dispensed onto the surface. After a delay of
3 seconds, 4.5 µl of sample was reaspirated into the pipette tip
before samples were infused into the mass spectrometer via
chip-based electrospray ionisation. Samples were infused with a
gas pressure of 0.3 PSI and an ionisation voltage of 1.7 kV.
UltraFAIMS
FAIMS was carried out in positive ion mode using a miniatur-
ized ultraFAIMS device (Owlstone, Cambridge, UK), using a
NC chip with a trench length of 78.1 mm and a gap of
101.3 μm and a thickness of 700 μm. The FAIMS device was
interfaced to an Orbitrap Velos (Thermo Scientific, UK) mass
spectrometer. 2D FAIMS: separation was performed at eight
discrete dispersion fields (DFs) between 130 Td and 270 Td
with step size 20 Td. At each DF, the compensation field (CF)
was varied between −1 to +4 Td over a 180 s time period. Static
FAIMS: optimal DF and CF conditions for the transmission of
ions of interest were selected from the 2D FAIMS analysis. For
transmission of lipids the conditions were DF = 130 Td and
CF = 1.8 Td.
Mass spectrometry
2D FAIMS experiments were performed on a Thermo Fisher
Orbitrap Velos mass spectrometer at a resolution of 100 000 at
m/z 400. Static FAIMS and HCD experiments were performed
on a Thermo Fisher Orbitrap Elite mass spectrometer at a
resolution of 120 000 at m/z 400. Full scan mass spectra were
collected in the Orbitrap between m/z 600–2000. The AGC
target was 1 × 106 charges with a maximum injection time of
1000 ms. Each scan was composed of 1 microscan. MS/MS:
precursor ions were selected for fragmentation in the linear
ion trap (isolation width 2 Th). HCD experiments (NCE
18–20%) were recorded at a resolving power of 120 000 at m/z
400. AGC target was 2 × 104 charges with maximum injection
time 1000 ms. Each scan comprised 1 microscan. MS/MS
spectra shown comprise 125 co-added scans (3 minutes
of data).
Data analysis
Data were converted from Thermo.raw format to mzML using
msconvert as part of ProteoWizard34 and then to imzML using
imzMLConverter.35 Data in the imzML format were then
loaded into MATLAB (version 2013, The MathWorks Inc.,
Natick, Massachusetts) using imzMLConverter and in-house
software. Total ion transmission maps and single ion trans-
mission maps were generated as described in ref. 28, further
implemented to allow generation of three dimensional total
ion transmission maps. Software for generation of total ion
transmission maps and single ion transmission maps,
together with a step-by-step guide, is available for
download from http://www.biosciences-labs.bham.ac.uk/
cooper/software.html.
Lipid assignment
Abundant lipid species detected from DBS samples were
identified by a combination of higher energy collision dis-
sociation (HCD) and accurate mass (5 ppm tolerance) via
cross-referencing with the LIPID MAPS database.36,37 Lower
abundance species were assigned solely on the basis of accu-
rate mass (5 ppm tolerance) with cross referencing against the
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LIPID MAPS database. MS/MS spectra were analysed manually
in Xcalibur version 3.0.63 (Thermo Fisher).
Results and discussion
The LESA Nanomate robot was coupled to the Owlstone ultra-
FAIMS device, which in turn was coupled to a high mass
resolution Orbitrap mass spectrometer. LESA sampling of DBS
on filter paper was coupled with a 2D FAIMS analysis in which
the dispersion field (DF) was varied between 130 and 270 Td
and the compensation field (CF) was varied between −1 and 4
Td. Fig. 1 (Panels A–H) show the total ion transmission maps
(m/z versus CF) obtained at each of the dispersion fields (DF
130 to 270 Td in increments of 20 Td). Fig. 1 (Panels I–P) show
the same data plotted as three dimensional total ion trans-
mission maps. Displaying the data in this way oﬀers insight as
to the global changes aﬀorded by changing DF. It is evident
from these maps that increasing DF results in transmission of
ions across a greater range of compensation fields. Similar be-
haviour was observed for LESA FAIMS analysis of thin tissue
sections.28 The striations apparent in the 2D total ion trans-
mission maps correspond to the various charge states of the
protein ions. These features are particularly noticeable here
due to the high concentration of haemoglobin in these
samples. ESI Fig. 1† shows the 2D total ion transmission map
obtained at 270 Td (Panel H) together with the averaged mass
spectrum acquired during this 3 minute experiment overlaid.
Fig. 1 (A) to (H): 2-dimensional total ion transmission maps (m/z vs. compensation ﬁeld (CF)) obtained following LESA-FAIMS mass spectrometry of
dried blood spots at dispersion ﬁelds DF = 130 Td, 150 Td, 170 Td, 190 Td, 210 Td, 230 Td, 250 Td and 270 Td. (I) to (P): 3-dimensional total ion
transmission plots of the same data showing signal intensity in the z axis, with a mean mass spectrum projected in red and total ion chromatogram
projected in blue.
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It is clear from this figure that the high intensity strata in the
total ion transmission map correlate to α-globin and β-globin
ions in charge states varying from +14 to +20.
Single ion transmission maps for the various charge states
of α- and β-globin, in which the transmission of specific m/z
values according to DF and CF, are shown in ESI Fig. 2.† It is
evident from these maps that the transmission of each globin
chain did not diﬀer significantly from the other; hence the use
of the FAIMS field did not enable separation of the α- and
β-globin chains. Lower charge state ions were transmitted from
lower CF values than higher charge state ions, and higher
charge state ions were transmitted over a broader CF range as
DF increased. Brown et al. have described similar results; that
multiply charged peptides are transmitted at higher compen-
sation fields when compared to lower charge state peptides.38
Blood constitutes a complex mixture of proteins, many of
which have been identified from DBS samples. Martin et al.
reported identification of 120 diﬀerent proteins in a single
dried blood spot10 following LESA sampling coupled with
automated tryptic digestion. Nevertheless, no proteins other
than the globins were observed following LESA FAIMS. That is,
the inclusion of FAIMS could not mitigate the issue of
dynamic range for the analysis of proteins in DBS.
The main benefit in coupling FAIMS with LESA analysis of
dried blood spots arises from the ability to separate molecular
classes, i.e., lipids and proteins. Fig. 2A shows the LESA mass
spectrum obtained from DBS in the absence of FAIMS. Clearly,
the most abundant species are the α- and β-globin protein
ions. Peaks observed at m/z 757, 797, 841, 890, 946, 1009 and
1081 correspond to the +20 to +14 charge states of α-globin,
and those at m/z 882, 934, 992, 1058 and 1134 correspond to
the +18 to +14 charge states of β-globin. By introducing FAIMS
into the workflow, it is possible to focus the protein ions. The
total ion transmission map obtained at DF = 130 Td (Fig. 1A)
shows the region of FAIMS DF/CF space populated by globin
ions is more confined than when compared with that obtained
at DF = 270 Td. This focusing of haemoglobin protein ions at
DF = 130 Td enables the separation of lipid species. Fig. 2B
shows the averaged mass spectrum obtained in the CF range
0.18 to 1.54 Td at DF = 130 Td. The peaks observed correspond
to the α-globin and β-globin ions in various charge states.
Fig. 2C shows the averaged mass spectrum obtained in the CF
range 1.78 to 3.86 Td at DF = 130 Td. The mass spectrum is
dominated by peaks corresponding to singly-charged lipid
species (which were not observed in the absence of FAIMS)
and peaks corresponding to haemoglobin are observed in the
+20 and +19 charge states only.
A two dimensional FAIMS analysis (in which DF and CF are
varied) enables identification of optimum FAIMS conditions
for transmission of a particular (set of) ions.28 A static FAIMS
analysis (in which DF and CF are constant) can subsequently
be performed. In the present case, lipid species from DBS were
Fig. 2 (A) LESA mass spectrum obtained from a DBS in the absence of FAIMS; (B) LESA FAIMS mass spectrum obtained from a DBS (2D FAIMS: DF
130 Td, CF = 0.18–1.54 Td); (C) LESA FAIMS mass spectrum obtained from a DBS (2D FAIMS: DF = 130 Td, CF = 1.78–3.86 Td); (D) LESA FAIMS mass
spectrum obtained from a DBS (static FAIMS: DF = 130 Td, CF = 1.8 Td).
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optimally transmitted under the following conditions: DF 130
Td and CF 1.8 Td. Fig. 2D shows an example mass spectrum
acquired under these experimental conditions. (Mass spec-
trum comprises 1 minute of data (42 scans)). Lipid species
were assigned by a combination of MS/MS and accurate mass
cross-referencing against the LIPID MAPS database.36,37
Higher-energy collision dissociation (HCD) of the abundant
precursor ions with m/z 758.6, 760.6, 782.6 and 786.6 resulted
in detection of one predominant product ion at m/z 184.1, see
ESI Fig. 3,† which corresponds to the protonated phosphatidyl-
choline (PC) headgroup.39 A number of further species, with
insuﬃcient abundance to acquire MS/MS data, were assigned
by accurate mass as protonated phospholipid species, either
phosphatidylcholine (PC) or phosphatidylethanolamine (PE)
species, and sphingomyelin species (SM). Lipid assignments
are summarised in Table 1.
In order to probe the reproducibility of the LESA FAIMS
approach for analysis of lipids from DBS, static FAIMS experi-
ments were performed. Two biological replicates were each
analysed at four separate locations at two time points (1 day
after sample collection and 6 days after sample collection).
The results are shown in Fig. 3. For each set of technical repli-
cates (for each lipid m/z, at each time point from each biologi-
cal sample), the reproducibility was good. (Error bars indicate
one standard deviation). The variation between biological
replicates was greater on day 1 than on day 6, although the
variation was only significant (p < 0.05 as given by a Student’s
t-test) for m/z 813.7 (SMd42:2) on day 1, and for m/z 786.6 (PC
36:2) on day 6. For biological replicate 1, the variation between
time points was significant (p < 0.05) for m/z 758.6 (PC 34:2)
and very significant (p < 0.01) for m/z 760.6 (PC 34:1) and m/z
810.6 (PC 38:4 or PE 41:4). For biological replicate 2, the vari-
ation in relative abundance was significant (p < 0.05) for m/z
786.6 (PC 36:2) and very significant (p < 0.01) for m/z 810.6 (PC
38:4 or PE 41:4). These results suggest that (a) reproducibility
between technical replicates is high, (b) the (expected) vari-
ation between biological replicates is clearer in samples that
are 1 day old, (c) some lipid degradation occurs after 6 days.
Further work to characterise the latter is warranted.
The lipid species identified are major components of cell
membranes and therefore play an important structural role.
The phosphatidylcholine lipids PC 34:2, 36:2, and 38:4
observed here were also detected directly from dried blood
spot samples via paperspray ionisation coupled with a triple
quadrupole mass spectrometer by Espy et al.40 The results
here show a wider range of lipid species can be detected
directly from dried blood spots via LESA FAIMS mass spec-
trometry. As described above, a number of researchers have
used the DBS sample format as a platform for studying phos-
pholipids. In each case, the researchers employed lengthy
extraction procedures in order to extract the reported lipid
species from the dried blood spot samples. For example,
Denes et al. extracted samples in methanol for 30 minutes and
then mixed the sample as a 1 : 1 mixture with water before ESI
mass spectrometry using the Triversa Nanomate robot.27 Our
results show direct surface sampling (LESA) coupled with
FAIMS leads to the detection of an increased number of
Table 1 Lipid species identiﬁed in LESA FAIMS mass spectrometry ana-
lysis of DBS at DF = 130 Td and CF = 1. 8 Td. A number of phospholipid
and sphingomyelin species are identiﬁed within 5 ppm error. * indicates
lipids identiﬁed on the basis of MS/MS
Measured,
m/z
Calculated,
m/z
Δ,
ppm Assignment
758.5673 758.5694 2.8 *PC 34:2 [M + H]+
760.5833 760.5851 2.4 *PC 34:1 [M + H]+
782.5668 782.5694 3.3 *PC 36:4 [M + H]+
784.5828 784.5851 2.9 PC 36:3 or PE 39:3 [M + H]+
786.5984 786.6007 2.9 *PC 36:2 [M + H]+
787.6670 787.6687 2.2 SM(d40:1) [M + H]+
788.6132 788.6164 4.1 PC 36:1 or PE 39:1 [M + H]+
810.5987 810.6007 2.5 PC 38:4 or PE 41:4 [M + H]+
811.6661 811.6687 3.2 SM(d42:3) [M + H]+
813.6824 813.6844 2.5 SM(d42:2) [M + H]+
815.6990 815.7000 1.2 SM(d42:1) [M + H]+
Fig. 3 Relative abundances of the 6 most abundant lipid species detected during LESA FAIMS mass spectrometry analysis of DBS (DF = 130 Td; CF
= 1.8 Td) at (A) 1 day and (B) 6 days after sample collection. Each biological replicate and time point is represented by 4 technical replicates. Error
bars show one standard deviation.
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diﬀerent phospholipid species in a much shorter analysis time
and using more straightforward experimental methods.
Although a wider range of lipid species have been reported
in other investigations (Koulman et al. describe the detection
of a range of PCs, PEs, SMs, TAGs and CEs in the mass range
m/z 640–1000 from infant samples25), the initial results
described in this study are promising. Inclusion of the FAIMS
device in the mass spectrometry workflow reduces the require-
ment for lengthy extraction procedures to monitor phospho-
lipid and sphingomyelin species from these samples.
Optimisation of the extraction solvent used for LESA-FAIMS
experiments could increase the number of lipid classes
detected from dried blood spot samples and work in this area
is ongoing.
As described above, Edwards et al. have shown it is possible
unambiguously assign a number of haemoglobin variants via
LESA sampling of newborn DBS.8,11,19 Furthermore, Koulman
et al. showed that monitoring of lipid species in newborn DBS
is a suitable approach for determining lipid metabolism.25
The method presented here could be tailored for the targeted
analysis of a range of analytes, such as proteins and lipid
species, in a single analysis. This finding has implications for
the clinic: it is feasible that metabolites, for instance phospho-
lipids, could be monitored alongside haemoglobin variants,
directly from a single extraction from a dried blood spot
sample simply by varying the FAIMS parameters. Moreover,
the analysis time is short: the protein mass spectrum shown in
Fig. 2B was recorded in <20 seconds and the lipid mass spec-
trum in Fig. 2C in <60 seconds. Hence it would be possible to
acquire both protein and lipid data within 90 seconds of ana-
lysis time.
Conclusions
LESA FAIMS mass spectrometry is presented as a tool for the
analysis of dried blood spots. The approach allows the separ-
ation of highly abundant haemoglobin ions from lower abun-
dance lipid ions which could not be detected in the absence of
FAIMS. It was not possible to separate the individual globin
units (α and β) by use of the ultraFAIMS, nor were any
additional proteins identified. A range of lipids were identified
including phosphatidylcholine or phosphatidylethanolamine
and sphingomyelin species. These species are biologically rele-
vant and have previously been shown to be potential targets in
the screening of diseases in newborns. LESA FAIMS mass
spectrometry of DBS could find application in the clinic for
multiplexed screening assays, i.e., monitoring of haemoglobin
variants and lipids in a single analysis.
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